ExThera Medical unveils promising data from a study of its Seraph blood-filtering device in the treatment of drug-resistant strains of E. coli and pneumonia.
ExThera Medical unveiled promising data from a study of its Seraph blood-filtering device in the treatment of drug-resistant strains of E. coli and pneumonia.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1CZ53Xw
Cap comentari:
Publica un comentari a l'entrada